Sophia Randolph - Dec 16, 2022 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Medical Officer, Director
Signature
/s/ Peter Garcia, by power of attorney
Stock symbol
ALXO
Transactions as of
Dec 16, 2022
Transactions value $
$189,875
Form type
4
Date filed
12/20/2022, 04:08 PM
Previous filing
Aug 9, 2022
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Options Exercise $16.1K +8.4K +3.73% $1.91 234K Dec 16, 2022 Direct
transaction ALXO Common Stock Options Exercise $51.9K +12.7K +5.45% $4.08 247K Dec 16, 2022 Direct
transaction ALXO Common Stock Options Exercise $122K +25.3K +10.28% $4.81 272K Dec 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Stock Option (right to buy) Options Exercise $0 -8.4K -67.61% $0.00 4.03K Dec 16, 2022 Common Stock 8.4K $1.91 Direct F1
transaction ALXO Stock Option (right to buy) Options Exercise $0 -12.7K -11.8% $0.00 95.2K Dec 16, 2022 Common Stock 12.7K $4.08 Direct F2
transaction ALXO Stock Option (right to buy) Options Exercise $0 -25.3K -50% $0.00 25.3K Dec 16, 2022 Common Stock 25.3K $4.81 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.
F2 The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.